Dengjiao Ma

Title: Innovations of Dengjiao Ma in Antibacterial Medicaments

Introduction

Dengjiao Ma is an accomplished inventor based in Sichuan, China. He has made significant contributions to the field of medicine, particularly in the development of novel antibacterial treatments. His work focuses on human coagulation factor light-chain proteins and their applications in combating Gram-negative bacterial infections.

Latest Patents

Dengjiao Ma holds a patent for "Human coagulation factor light chain protein and use of the same." This invention involves detecting the minimum inhibitory concentrations of human coagulation factor light-chain proteins against various Gram-negative bacteria. The research demonstrates that these proteins exhibit a notable inhibitory effect on Gram-negative bacteria, paving the way for new medicaments aimed at treating such infections. Additionally, it has been shown that these proteins can hydrolyze and eliminate endotoxins, further supporting the development of treatments for endotoxemia.

Career Highlights

Dengjiao Ma is associated with Chengdu Sourcebio Limited-Liability Company, where he continues to innovate in the field of medical research. His work has garnered attention for its potential to address significant health challenges posed by bacterial infections.

Collaborations

Dengjiao Ma collaborates with notable colleagues, including Xu Song and Ling Li, who contribute to his research endeavors. Their combined expertise enhances the development of effective medical solutions.

Conclusion

Dengjiao Ma's innovative work in the field of antibacterial medicaments showcases the potential of human coagulation factor light-chain proteins in medical applications. His contributions are vital in the ongoing fight against bacterial infections and endotoxemia.